MRI features of primary central nervous system lymphomas at presentation

被引:236
作者
Bühring, U
Herrlinger, U
Krings, T
Thiex, R
Weller, M
Küker, W
机构
[1] Univ Tubingen, Sch Med, Dept Neuroradiol, D-72076 Tubingen, Germany
[2] Univ Tubingen, Sch Med, Dept Neurol, D-72076 Tubingen, Germany
[3] Rhein Westfal TH Aachen, Sch Med, Dept Neuroradiol, Aachen, Germany
[4] Rhein Westfal TH Aachen, Sch Med, Dept Neurosurg, Aachen, Germany
关键词
D O I
10.1212/WNL.57.3.393
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pretreatment MRI examinations of 40 immunologically competent patients with primary CNS lymphoma (PCNSL) were evaluated (24 men, 16 Women, median age 63 years). Seventy lesions were found (mean size: 19.9 mm). The number of lesions ranged from one (n = 25) to six (n = 1). The most frequent locations were the cerebral hemispheres (n = 22), the corpus callosum (n = 11), and the basal ganglia (n = 11). Cerebellar manifestations were found in 10 patients. Ocular (n = 2) and medullary cord (n = 1) manifestations were rare. Contrast enhancement was encountered in all lesions. Although 39 patients had lesions adjacent to the CSF space, leptomeningeal spread was only present in five patients. Necrosis was seen in two lesions only. Edema was extensive in 24 patients, moderate in 11 patients, and absent in five patients. Contrast-enhancing lesions in contact with the subarachnoid space and without necrosis are characteristic of PCNSL.
引用
收藏
页码:393 / 396
页数:4
相关论文
共 18 条
  • [1] Treatment for primary CNS lymphoma: The next step
    Abrey, LE
    Yahalom, J
    DeAngelis, LM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3144 - 3150
  • [2] Intracranial sarcomatous tumors of leptomeningeal origin
    Bailey, P
    [J]. ARCHIVES OF SURGERY, 1929, 18 (04) : 1359 - 1402
  • [3] EBY NL, 1988, CANCER, V62, P2461, DOI 10.1002/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO
  • [4] 2-M
  • [5] CT APPEARANCE OF PRIMARY CNS LYMPHOMA IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    GOLDSTEIN, JD
    ZEIFER, B
    CHAO, C
    MOSER, FG
    DICKSON, DW
    HIRSCHFELD, AD
    DAVIS, L
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1991, 15 (01) : 39 - 44
  • [6] Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: Response to therapy and quality of life of patients
    Guha-Thakurta, N
    Damek, D
    Pollack, C
    Hochberg, FH
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1999, 43 (03) : 259 - 268
  • [7] PCV salvage chemotherapy for recurrent primary CNS lymphoma
    Herrlinger, U
    Brugger, W
    Bamberg, M
    Küker, W
    Dichgans, J
    Weller, M
    [J]. NEUROLOGY, 2000, 54 (08) : 1707 - 1708
  • [8] Herrlinger U, 2001, CANCER, V91, P130, DOI 10.1002/1097-0142(20010101)91:1<130::AID-CNCR17>3.0.CO
  • [9] 2-8
  • [10] PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - AN UPDATE
    JELLINGER, KA
    PAULUS, W
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 119 (01) : 7 - 27